Literature DB >> 20674460

Occurrence of depression and anxiety prior to Parkinson's disease.

E L Jacob1, N M Gatto, A Thompson, Y Bordelon, B Ritz.   

Abstract

OBJECTIVE: To assess the relationship between depression and anxiety and Parkinson's disease (PD).
BACKGROUND: Many people with PD suffer from depression and anxiety prior to the onset of motor symptoms. Studies suggest these psychiatric conditions may be risk factors for PD or prodromal non-motor symptoms.
METHODS: Using a population-based approach in three California counties, we recruited 371 incident PD cases, 402 population and 115 sibling controls. We recorded self-reports of lifetime depression/anxiety diagnoses and use of psychotropic medications. We adjusted for age, race, sex, pack-years of smoking, and education, and also conducted analyses after excluding (lagging) both diagnoses and medication use first occurring within 2, 5, 10, and 20 years of the index/diagnosis date.
RESULTS: Cases were more likely to have received a diagnosis of depression or anxiety at any time prior to index date (OR 1.42, 95% CI 1.01, 2.00), but were not more likely to have been both diagnosed and treated (OR 1.11, 95% CI 0.77, 1.60). Male PD patients received diagnoses combined with treatment more often than population controls within 5 years of PD diagnosis (OR 2.21, 95% CI 1.21, 4.04; 2 year lag: OR 2.44, 95% CI 1.29, 4.61; 5 year lag: OR 1.67, 95% CI 0.80, 3.49). We did not see any differences for females. Results for cases compared to sibling controls were similar to those for population controls.
CONCLUSION: These results suggest that depression and anxiety may be early symptoms during the prodromal phase of PD.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674460      PMCID: PMC2963655          DOI: 10.1016/j.parkreldis.2010.06.014

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  34 in total

Review 1.  Quality of life and depression in Parkinson's disease.

Authors:  Anette Schrag
Journal:  J Neurol Sci       Date:  2006-06-21       Impact factor: 3.181

Review 2.  A systematic review of depression and mental illness preceding Parkinson's disease.

Authors:  L Ishihara; C Brayne
Journal:  Acta Neurol Scand       Date:  2006-04       Impact factor: 3.209

Review 3.  Depression in Parkinson's disease -- a review.

Authors:  A Lieberman
Journal:  Acta Neurol Scand       Date:  2006-01       Impact factor: 3.209

4.  Clinical characteristics in early Parkinson's disease in a central California population-based study.

Authors:  Gail A Kang; Jeff M Bronstein; Donna L Masterman; Matthew Redelings; Jarrod A Crum; Beate Ritz
Journal:  Mov Disord       Date:  2005-09       Impact factor: 10.338

Review 5.  A systematic review of prevalence studies of depression in Parkinson's disease.

Authors:  Jennifer S A M Reijnders; Uwe Ehrt; Wim E J Weber; Dag Aarsland; Albert F G Leentjens
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

6.  Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease.

Authors:  M T Tadaiesky; P A Dombrowski; C P Figueiredo; E Cargnin-Ferreira; C Da Cunha; R N Takahashi
Journal:  Neuroscience       Date:  2008-09-09       Impact factor: 3.590

Review 7.  Depressive symptoms in Parkinson's disease.

Authors:  M R Lemke
Journal:  Eur J Neurol       Date:  2008-04       Impact factor: 6.089

8.  Quality of life in Parkinson's disease: the relative importance of the symptoms.

Authors:  Shibley Rahman; Harry J Griffin; Niall P Quinn; Marjan Jahanshahi
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

9.  Predictors and course of health-related quality of life in Parkinson's disease.

Authors:  Elin Bjelland Forsaa; Jan Petter Larsen; Tore Wentzel-Larsen; Karen Herlofson; Guido Alves
Journal:  Mov Disord       Date:  2008-07-30       Impact factor: 10.338

Review 10.  The premotor phase of Parkinson's disease.

Authors:  E Tolosa; Y Compta; C Gaig
Journal:  Parkinsonism Relat Disord       Date:  2007-07-27       Impact factor: 4.891

View more
  43 in total

Review 1.  Premotor Diagnosis of Parkinson's Disease.

Authors:  Heinz Reichmann
Journal:  Neurosci Bull       Date:  2017-08-03       Impact factor: 5.203

Review 2.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

3.  Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin.

Authors:  Shannon L Rhodes; Daniel D Buchanan; Ismaïl Ahmed; Kent D Taylor; Marie-Anne Loriot; Janet S Sinsheimer; Jeff M Bronstein; Alexis Elbaz; George D Mellick; Jerome I Rotter; Beate Ritz
Journal:  Neurobiol Dis       Date:  2013-10-08       Impact factor: 5.996

4.  Daytime napping, nighttime sleeping, and Parkinson disease.

Authors:  Jianjun Gao; Xuemei Huang; Yikyung Park; Albert Hollenbeck; Aaron Blair; Arthur Schatzkin; Honglei Chen
Journal:  Am J Epidemiol       Date:  2011-03-14       Impact factor: 4.897

5.  Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study.

Authors:  A J Clark; B Ritz; E Prescott; N H Rod
Journal:  Eur J Neurol       Date:  2013-02-23       Impact factor: 6.089

6.  Depression and subsequent risk of Parkinson disease: A nationwide cohort study.

Authors:  Helena Gustafsson; Anna Nordström; Peter Nordström
Journal:  Neurology       Date:  2015-05-20       Impact factor: 9.910

7.  [Coexistent depressive and anxiety disorders in neurological diseases: from a perspective of multimorbidity].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2014-04       Impact factor: 1.214

8.  Household organophosphorus pesticide use and Parkinson's disease.

Authors:  Shilpa Narayan; Zeyan Liew; Kimberly Paul; Pei-Chen Lee; Janet S Sinsheimer; Jeff M Bronstein; Beate Ritz
Journal:  Int J Epidemiol       Date:  2013-09-20       Impact factor: 7.196

9.  The association between ambient exposure to organophosphates and Parkinson's disease risk.

Authors:  Anthony Wang; Myles Cockburn; Thomas T Ly; Jeff M Bronstein; Beate Ritz
Journal:  Occup Environ Med       Date:  2014-01-16       Impact factor: 4.402

10.  Motor symptoms at onset of Parkinson disease and risk for cognitive impairment and depression.

Authors:  Richard B Dewey; Aanchal Taneja; Shawn M McClintock; C Munro Cullum; Richard B Dewey; Ira Bernstein; Mustafa M Husain
Journal:  Cogn Behav Neurol       Date:  2012-09       Impact factor: 1.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.